A recent publication details the use of imusyn's IVD DaraEx plus to mitigate the interference of anti-CD38 antibodies in the IAT ⧉.
DaraEx plus is available from inno-train ⧉.
New Versions of the IFU for DaraEx plus and DaraEx are now available (release 2024/07/01).
EN ISO 13485:2016, issued May 09th, 2023
Certificate Directive 98/79/EC, issued May 20th, 2022
Our mission is to develop and produce outstanding diagnostic tests in the field of transfusion medicine and organ transplantation. We also support the development of in-vitro diagnostics and provide customized recombinant protein production.
We are pleased that we will be part of the annual Joint Meeting of DGTI & DGI 2024 in Düsseldorf. We are looking forward to interesting presentations and inspiring discussions.
11.09.2024 / 10:30 - 11:00 / Session Immunohematology and immunogenetics
Elimination of Anti-CD47 drug interference in serological testing by antigen masking
Clemens Schneeweiß / Cora P. Habicht (Hanover / DE)
13.09.2024 / 12:15 - 12:30 / Industry Symposium 7
Praktischer Ansatz und Abrechnung von DaraEx plus
Corinna Nöcker (Essen / DE)
13.09.2024 / 12:35 - 12:50 / Industry Symposium 7
From DaraEx to Dyemers – Immunotherapy’s Little Helpers in Diagnostics and Research
Clemens Schneeweiß (Hanover / DE)
Poster Exhibition P-15-1
Mezagitamab interference in serological testing can be eliminated with anti-CD38 fab fragments
Clemens Schneeweiß / Cora P. Habicht (Hanover / DE)